Driving innovation and enabling diagnostic excellence, from Sample to Insight

December 12, 2023 | 9:30 a.m.–1 p.m. | Cape Town International Conference Centre, meeting room 1.6.1 – 1.6.2

This half-day symposium at ASLM2023 is designed to propel the field of medical diagnostics forward. Through a series of presentations and discussions, our experts will showcase cutting-edge innovations and strategies in diagnostic technology and methodologies. The event aims to foster collaboration, share insights, and drive the evolution of diagnostic excellence across experts, researchers, healthcare professionals, and industry leaders.

Don't miss this opportunity to be part of a platform that fosters knowledge sharing, innovation, and the future of diagnostic excellence in healthcare. Join us to gain firsthand insights, forge connections with peers and industry experts, and actively contribute to the advancement of diagnostic technologies and methodologies.

Who should attend?
  • Healthcare professionals
  • Researchers in diagnostics
  • Medical technology innovators
  • Policymakers in the health sector
  • Students in medical and biotechnological fields

Display agenda

Time Topic Details Speaker
9:30–10:15 a.m. Welcome and introduction
  • Introduction to QIAGEN and its role in diagnostics innovation
Ms. Jacqueline Karachi | Associate Director Marketing Regional, QIAGEN
10:15–11 a.m. Why latent TB is relevant: Prevent TB to End TB
  • The global impact of TB and the importance of addressing and ending latent TB
  • Strategies and innovations in TB diagnosis and management
Dr. Vladyslav Nikolayevskyy | Director Medical Affairs, QIAGEN
Ms. Stephanie Salloum | Regional Marketing Manager Immune Response, QIAGEN
11–11:30 a.m.
11:30 a.m.–12:15 p.m. Beyond centralized testing for HPV: QIAsure
  • Exploring advancements in Human Papillomavirus (HPV) testing
  • QIAsure: The value of methylation specific PCR assay in Triage of hrPHV positive women
Tandie Mpabanga-Nyathi | Senior Manager Sales Development QFT, QIAGEN
12:15–1:00 p.m. Syndromic testing: An alternative approach to the diagnosis of meningitis
  • Overview of current challenges in meningitis diagnosis
  • Introducing syndromic testing methodologies and their benefits
Ms. Reeva Daniels | Customer Solutions Manager, QIAGEN

Thanks for your interest, we hope to see you soon.

Not signed up for My QIAGEN yet? Whether you’d like to quickly check your order status or reorder, download free resources or simply get support – My QIAGEN is at your service. Use our fast registration process to sign up and get access to all your benefits today! My QIAGEN is at your service, 24/7. Sign up for an account here.

Benefits of My QIAGEN
  • 24/7 follow-up on your past orders and requests
  • Relevant product recommendations and content
  • Exclusive access to state-of-the-art documentation and events
Register for MY QIAGEN

Submit form to register for half-day symposium

Dummy field DO NOT USE/ DELETE/ MODIFY Needs to be hidden in CSS on LP
Script on LP to collect URL
Required only for USA & Canada
I hereby give QIAGEN my consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

* Mandatory fields

† By checking the box above, you submit your information to QIAGEN, who will use it to communicate with you regarding this topic. QIAGEN may also use your personal information for internal business and marketing purposes, including but not limited to webinar and raffle registration, product, trial, educational and events information. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) and our commercial partners solely for the purposes of data hosting, phone calls and QIAGEN email distribution. You may unsubscribe at any time. If you withdraw your consent we will not be able to communicate with you on this topic. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation. For further details please refer to our Privacy Policy.